[Federal Register Volume 86, Number 138 (Thursday, July 22, 2021)]
[Notices]
[Pages 38729-38730]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-15547]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and contract proposals and 
the discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications and 
contract proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Diagnosis and Treatment of Pediatric and Rare Cancers.
    Date: September 16-17, 2021.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W260, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W260, Rockville, Maryland 20850, 240-276-5856, 
<a href="/cdn-cgi/l/email-protection#c6a8a7a2a3a3abe8adaea7a886a8afaee8a1a9b0"><span class="__cf_email__" data-cfemail="c3ada2a7a6a6aeeda8aba2ad83adaaabeda4acb5">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; K22 Transition Career Development Award.
    Date: September 21, 2021.
    Time: 10:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W234, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Adriana Stoica, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W234, Rockville, Maryland 20850, 240-276-6368, 
<a href="/cdn-cgi/l/email-protection#a7f4d3c8cec4c6c695e7cac6cecb89c9cecf89c0c8d1"><span class="__cf_email__" data-cfemail="dd8ea9b2b4bebcbcef9db0bcb4b1f3b3b4b5f3bab2ab">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Program Project I (P01).
    Date: October 6-7, 2021.
    Time: 9:00 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W618, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Mukesh Kumar, Ph.D., Scientific Review Officer, 
Research Program Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W618, Rockville, Maryland 20850, 240-276-6611, 
<a href="/cdn-cgi/l/email-protection#7d100816180e15531608101c0f4e3d131415531a120b"><span class="__cf_email__" data-cfemail="5f322a343a2c3771342a323e2d6c1f31363771383029">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Program Project II.
    Date: October 12-13, 2021.
    Time: 9:30 a.m. to 6:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W116, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Klaus B. Piontek, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W116, Rockville, Maryland 20850, 240-276-5413, 
<a href="/cdn-cgi/l/email-protection#f59e99948086db859c9a9b81909eb59b9c9ddb929a83"><span class="__cf_email__" data-cfemail="b0dbdcd1c5c39ec0d9dfdec4d5dbf0ded9d89ed7dfc6">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI SPORE (P50) Review I.
    Date: October 13-14, 2021.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W242, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: John Paul Cairns, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W242, Rockville, Maryland 20850, 240-276-5415, 
<a href="/cdn-cgi/l/email-protection#d1a1b0a4bdffb2b0b8a3bfa291bfb8b9ffb6bea7"><span class="__cf_email__" data-cfemail="9eeeffebf2b0fdfff7ecf0eddef0f7f6b0f9f1e8">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI SPORE (P50) Review II.
    Date: October 14, 2021.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W248, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Anita T. Tandle, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W248, Rockville, Maryland 20850, 240-276-5085, 
<a href="/cdn-cgi/l/email-protection#97e3f6f9f3fbf2f6d7faf6fefbb9f9feffb9f0f8e1"><span class="__cf_email__" data-cfemail="a8dcc9c6ccc4cdc9e8c5c9c1c486c6c1c086cfc7de">[email protected]</span></a>.


[[Page 38730]]


    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Program Project III.
    Date: October 20-21, 2021.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W648, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Michael E. Lindquist, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W648, Rockville, Maryland 20850 <a href="/cdn-cgi/l/email-protection#2e4347454b004247404a5f5b475d5a6e40474600494158"><span class="__cf_email__" data-cfemail="e88581838dc68481868c999d819b9ca8868180c68f879e">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Technologies for Basic and Clinical Cancer Research.
    Date: October 28-29, 2021.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W260, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W260, Rockville, Maryland 20850, 240-276-5856, 
<a href="/cdn-cgi/l/email-protection#234d424746464e0d484b424d634d4a4b0d444c55"><span class="__cf_email__" data-cfemail="4628272223232b682d2e272806282f2e68212930">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: July 16, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-15547 Filed 7-21-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>